Genital Diseases, Female  >>  erlotinib  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
erlotinib / Generic mfg.
NCT00263822 / 2004-004333-34: Erlotinib or Observation in Treating Patients Who Have Undergone First-Line Chemotherapy for Ovarian Cancer, Peritoneal Cancer, or Fallopian Tube Cancer

Checkmark Vs. observation in pts with no evidence of disease progression after first-line platin-based chemo
Dec 2013 - Dec 2013: Vs. observation in pts with no evidence of disease progression after first-line platin-based chemo
Checkmark P3 data - ASCO
Jun 2012 - Jun 2012: P3 data - ASCO
Completed
3
835
Europe, RoW
erlotinib hydrochloride
European Organisation for Research and Treatment of Cancer - EORTC
Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
02/08
 

Download Options